RespireRx Pharmaceuticals Inc.
RSPI
$0.0021
$0.0011110.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6,300.00% | -- | -66.67% | -92.86% | -83.33% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -6.34% | -0.64% | -7.18% | -23.05% | -17.75% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 114.82% | 81.85% | -7.16% | -89.08% | -78.00% |
|
|
|||||
| Total Current Assets | 114.82% | 81.85% | -7.16% | -89.08% | -78.00% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 114.82% | 81.85% | -7.16% | -89.08% | -78.00% |
|
|
|||||
| Total Accounts Payable | -32.82% | -50.74% | -51.12% | 5.44% | 14.63% |
| Total Accrued Expenses | -13.68% | 17.78% | 26.64% | 26.35% | 29.97% |
| Short-term Debt | 8.82% | 18.74% | 17.00% | 30.35% | 37.70% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 812.74% | 911.18% | 953.15% | 34.23% | 0.00% |
| Total Other Current Liabilities | 812.74% | 911.18% | 953.15% | 34.23% | 0.00% |
| Total Current Liabilities | 5.46% | 11.25% | 14.76% | 18.21% | 22.68% |
|
|
|||||
| Total Current Liabilities | 5.46% | 11.25% | 14.76% | 18.21% | 22.68% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 8.82% | 18.74% | 17.00% | 30.35% | 37.70% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 68.63% | -68.38% | -54.92% | -40.82% | -38.55% |
| Total Liabilities | 6.56% | 9.58% | 13.08% | 16.51% | 20.57% |
|
|
|||||
| Common Stock & APIC | 0.18% | 0.13% | 0.14% | 0.14% | 0.26% |
| Retained Earnings | -1.02% | -1.07% | -0.96% | -1.21% | -1.49% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -12.88% | -14.90% | -13.25% | -18.67% | -22.93% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 3,637.79% | 2,999.08% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -12.88% | -14.90% | -13.25% | -18.67% | -22.93% |
| Total Preferred Equity | 3,637.79% | 2,999.08% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.09% | -9.08% | -13.27% | -18.71% | -22.98% |
|
|
|||||